Amphastar Pharmaceuticals Operating Margin 2012-2024 | AMPH
Current and historical operating margin for Amphastar Pharmaceuticals (AMPH) over the last 10 years. The current operating profit margin for Amphastar Pharmaceuticals as of September 30, 2024 is 25.15%.
| Amphastar Pharmaceuticals Operating Margin Historical Data |
| Date |
TTM Revenue |
TTM Operating Income |
Operating Margin |
| 2024-09-30 |
$0.72B |
$0.21B |
29.60% |
| 2024-06-30 |
$0.71B |
$0.23B |
32.26% |
| 2024-03-31 |
$0.68B |
$0.21B |
31.31% |
| 2023-12-31 |
$0.65B |
$0.20B |
30.54% |
| 2023-09-30 |
$0.60B |
$0.18B |
30.07% |
| 2023-06-30 |
$0.54B |
$0.13B |
24.21% |
| 2023-03-31 |
$0.52B |
$0.12B |
22.97% |
| 2022-12-31 |
$0.50B |
$0.11B |
21.69% |
| 2022-09-30 |
$0.48B |
$0.09B |
19.42% |
| 2022-06-30 |
$0.48B |
$0.10B |
20.17% |
| 2022-03-31 |
$0.46B |
$0.08B |
18.02% |
| 2021-12-31 |
$0.44B |
$0.07B |
15.98% |
| 2021-09-30 |
$0.41B |
$0.05B |
11.86% |
| 2021-06-30 |
$0.38B |
$0.03B |
7.29% |
| 2021-03-31 |
$0.37B |
$0.01B |
3.80% |
| 2020-12-31 |
$0.35B |
$0.01B |
3.14% |
| 2020-09-30 |
$0.34B |
$0.01B |
2.37% |
| 2020-06-30 |
$0.33B |
$0.01B |
1.80% |
| 2020-03-31 |
$0.33B |
$0.01B |
3.06% |
| 2019-12-31 |
$0.32B |
0 |
0.00% |
| 2019-09-30 |
$0.33B |
$0.00B |
0.61% |
| 2019-06-30 |
$0.33B |
$0.00B |
0.92% |
| 2019-03-31 |
$0.32B |
$-0.00B |
-0.32% |
| 2018-12-31 |
$0.30B |
$-0.01B |
-2.71% |
| 2018-09-30 |
$0.27B |
$-0.01B |
-4.53% |
| 2018-06-30 |
$0.25B |
$-0.02B |
-7.29% |
| 2018-03-31 |
$0.24B |
$-0.01B |
-5.39% |
| 2017-12-31 |
$0.24B |
$-0.00B |
-0.83% |
| 2017-09-30 |
$0.24B |
$-0.01B |
-2.05% |
| 2017-06-30 |
$0.25B |
$0.00B |
1.60% |
| 2017-03-31 |
$0.25B |
$0.01B |
4.74% |
| 2016-12-31 |
$0.26B |
$0.02B |
5.88% |
| 2016-09-30 |
$0.27B |
$0.03B |
12.69% |
| 2016-06-30 |
$0.27B |
$0.02B |
8.96% |
| 2016-03-31 |
$0.25B |
$0.00B |
1.57% |
| 2015-12-31 |
$0.25B |
$-0.01B |
-2.78% |
| 2015-09-30 |
$0.23B |
$-0.03B |
-12.12% |
| 2015-06-30 |
$0.23B |
$-0.03B |
-14.10% |
| 2015-03-31 |
$0.22B |
$-0.02B |
-10.36% |
| 2014-12-31 |
$0.21B |
$-0.02B |
-8.53% |
| 2014-09-30 |
$0.21B |
$-0.01B |
-3.81% |
| 2014-06-30 |
$0.21B |
0 |
0.00% |
| 2014-03-31 |
$0.22B |
$0.01B |
5.83% |
| 2013-12-31 |
$0.23B |
$0.02B |
7.39% |
| 2013-09-30 |
$0.23B |
$0.07B |
29.07% |
| 2013-06-30 |
$0.23B |
$0.12B |
54.67% |
| 2013-03-31 |
$0.21B |
$0.16B |
75.83% |
| 2012-12-31 |
$0.20B |
$0.20B |
100.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$1.894B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
